Ptc Therapeutics, Inc. · NASDAQ:PTCT

Almstead Neil Gregory sold 23,749 Ptc Therapeutics, Inc. shares (Form 4)

Traded Jun 22, 2026 · Filed Jun 24, 2026

On Jun 22, 2026, Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) sold 23,749 Ptc Therapeutics, Inc. shares at an average US$80.90 for US$1.92M under a trading plan, leaving 60,137 shares. Filed Jun 24, 2026 (Form 4).

Sold
23,749 shares
Price
US$80.90 average (US$80.61 to US$81.21)
Value
US$1.92M
Holding after
60,137 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CHIEF TECHNICAL OPS OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 22, 2026Common StockOption exercise23,749US$25.6983,886Direct
Jun 22, 2026Common StockSale12,130US$80.6171,756Direct
Jun 22, 2026Common StockSale11,619US$81.2160,137Direct

Source

View original at SEC

Related